- Ultragenyx Pharmaceutical Inc at Cowen Health Care Conference- Orphan CNS Panel Discussion TranscriptMar 07, 2023
- AVROBIO Inc Virtual Gaucher Disease Program Update TranscriptDec 07, 2022
- AVROBIO Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- AVROBIO Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
- AVROBIO Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Ultragenyx Pharmaceutical Inc, Alector Inc, Passage Bio Inc, AVROBIO Inc and Annexon Inc in the Orphan CNS Panel at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- AVROBIO Inc Cystinosis Update Call TranscriptFeb 09, 2022
- AVROBIO Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- AVROBIO Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 28, 2021
- AVROBIO Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- AVROBIO Inc at JMP Securities Life Sciences Virtual Conference TranscriptJun 17, 2021
- AVROBIO Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- AVROBIO Inc Presents new Clinical Data from Fabry Disease, Cystinosis and Gaucher disease Type 1 Programs TranscriptFeb 08, 2021
- AVROBIO Inc at ICR Virtual Conference TranscriptJan 14, 2021
- AVROBIO Inc Virtual R&D Day TranscriptNov 17, 2020
- AVROBIO Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) TranscriptOct 13, 2020
- AVROBIO Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Avrobio Inc at WORLDSymposium 2020 TranscriptFeb 11, 2020
- AVROBIO Inc Announces Positive Data from Clinical Trials of AVR-RD-01- Call TranscriptJul 15, 2019
AVROBIO Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon. And welcome once again to the 19th Annual Morgan Stanley Healthcare Conference. I'm one of the biotechnology analysts here. My name is David Lebowitz. Before we jump in, let me go through the requisite disclosures. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, I'm happy to have here for the next session from AVROBIO, the management team. If you could give us quick introductions on yourselves and really give us a top-level introduction on AVRO itself, what the company does and what its overall mission is?
Sure. Thank you, David. So my name is Geoff MacKay, President and CEO. And joining me on the fireside chat is Chris Mason, our Chief Science Officer; and Erik Ostrowski, our Chief
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)